Eugene P Rhee
Overview
Explore the profile of Eugene P Rhee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
133
Citations
6048
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bernard L, Yang J, Chen J, Sullivan V, Yu B, Rhee E, et al.
Clin J Am Soc Nephrol
. 2025 Mar;
PMID: 40067387
Background: Discovering metabolomic markers of dietary potassium may help improve dietary assessment of potassium and trace the impact of dietary potassium on chronic kidney disease (CKD) development. Methods: We included...
2.
Kim T, Surapaneni A, Leo H, Fino N, Inker L, Levey A, et al.
Am J Kidney Dis
. 2025 Jan;
PMID: 39848531
No abstract available.
3.
Simic P, Xie H, Zhang Q, Zhou W, Cherukuru R, Adams M, et al.
Am J Physiol Renal Physiol
. 2024 Dec;
328(2):F165-F172.
PMID: 39716914
Why fibroblast growth factor 23 (FGF23) levels increase markedly in chronic kidney disease (CKD) is unknown. Recently, we found that phosphate stimulates renal production of glycerol-3-phosphate (G-3-P), which circulates to...
4.
Chen T, Surapaneni A, Schmidt I, Waikar S, Coresh J, Liu H, et al.
Kidney Med
. 2024 Dec;
6(12):100921.
PMID: 39634331
Rationale & Objective: Individuals with chronic kidney disease (CKD) are at increased risk of morbidity and mortality, particularly as they progress to kidney failure. Identifying circulating proteins that underlie kidney...
5.
Lopez-Silva C, Surapaneni A, Schmidt I, Upadhyay D, Srivastava A, Palsson R, et al.
Kidney Med
. 2024 Dec;
6(12):100920.
PMID: 39634330
Rationale & Objective: Diabetic kidney disease (DKD) is one of the leading causes of end-stage kidney disease globally. We aim to identify proteomic and metabolomic correlates of histologically confirmed DKD...
6.
Al Awadhi S, Myint L, Guallar E, Clish C, Wulczyn K, Kalim S, et al.
Kidney Int Rep
. 2024 Sep;
9(9):2718-2726.
PMID: 39291216
Introduction: Uremic toxins contributing to increased risk of death remain largely unknown. We used untargeted metabolomics to identify plasma metabolites associated with mortality in patients receiving maintenance hemodialysis. Methods: We...
7.
Schmidt I, Surapaneni A, Zhao R, Upadhyay D, Yeo W, Schlosser P, et al.
Nat Commun
. 2024 Aug;
15(1):7368.
PMID: 39191768
The kidney tubules constitute two-thirds of the cells of the kidney and account for the majority of the organ's metabolic energy expenditure. Acute tubular injury (ATI) is observed across various...
8.
Li T, Grams M, Inker L, Chen J, Rhee E, Warady B, et al.
Clin Kidney J
. 2024 Jun;
17(6):sfae108.
PMID: 38859934
Background: There is interest in identifying novel filtration markers that lead to more accurate GFR estimates than current markers (creatinine and cystatin C) and are more consistent across demographic groups....
9.
Yeo W, Surapaneni A, Hasson D, Schmidt I, Sekula P, Kottgen A, et al.
J Am Soc Nephrol
. 2024 Jun;
PMID: 38844075
No abstract available.
10.
Awwad A, Rhee E, Grams M, Choles H, Sondheimer J, He J, et al.
BMC Nephrol
. 2024 May;
25(1):185.
PMID: 38816682
Background: Protein carbamylation, a post-translational protein modification primarily driven by urea, independently associates with adverse clinical outcomes in patients with CKD. Biomarkers used to quantify carbamylation burden have mainly included...